Methypred comprimate 4 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

methypred comprimate 4 mg

orion corporation - methylprednisolonum - comprimate - 4 mg

Phorcal unguent 3 mcg/g Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

phorcal unguent 3 mcg/g

kusum healthcare pvt.ltd - calcitriolum - unguent - 3 mcg/g

Yohimbex-Garmonia capsule Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

yohimbex-garmonia capsule

centrul stiintific de producere "uzina chimico-farmaceutica borsceagov" sai - o combinatie - capsule

Zitazonium comprimate 10 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zitazonium comprimate 10 mg

egis pharmaceuticals plc - tamoxifenum - comprimate - 10 mg

Axastrol comprimate filmate 1 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

axastrol comprimate filmate 1 mg

grindeks sa - anastrozolum - comprimate filmate - 1 mg

Firmagon Uniunea Europeană - română - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostate neoplasme - terapia endocrină - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Xtandi Uniunea Europeană - română - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostate neoplasme - terapia endocrină - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

ARIMIDEX 1 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

arimidex 1 mg

astrazeneca uk limited - anastrozolum - compr. film. - 1mg - antagonisti hormonali si substante inrudite inhibitori enzimatici

ZOLADEX 3,6 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zoladex 3,6 mg

astrazeneca uk limited - goserelinum - implant - 3,6mg - hormoni si substante inrudite analogi de gonadorelina

ZOLADEX LA 10,8 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zoladex la 10,8 mg

astrazeneca uk ltd. - goserelinum - implant - 10,8 mg - hormoni si substante inrudite analogi de gonadorelina